Biotech investment secured: the BioExpert Network ensures maximum returns
Capital Cell has combined the best of private equity investment and biotech innovation, to create a unique business model that makes biotech investment accessible to anyone, regardless of their level of expertise.
The secret lies in our thorough vetting process, which ensures that the early-stage investments we offer are high-quality opportunities with maximum chances of returns, saving investors from having to conduct extensive research or grapple with complex scientific concepts to know where to invest their money.
The BioExpert Network (BEN)
A Community of Experts
The cornerstone of our evaluation process is the BioExpert Network (BEN), a community of over 3,000 experts in life sciences, health, biotechnology and medicine. The collective wisdom of these highly qualified professionals ensures that only the best biotech investment opportunities make it to our platform.
The Wisdom of Crowds
Rather than relying on a single evaluator, we harness the collective intelligence of our expert community. The approach is grounded in the principle of “the wisdom of crowds”, the idea that a group of people are collectively smarter than individual experts in problem-solving, decision-making, innovation and prediction.
“It gives many people like me (scientist turned entrepreneur) the opportunity to get experience in and insights in projects at different stages and areas looking for investment.”
The BioExpert Network (BEN)
The Evaluation Process
When companies approach Capital Cell, they submit basic project information and a pitch deck to the BEN. The members are then invited to evaluate various aspects of their proposal, such as the team, science, innovation, and business potential. Only proposals that receive a positive evaluation from the BEN are eligible for an equity investment campaign on Capital Cell’s platform.
The BEN Community
Our expert community is made up of professionals in healthcare, biotechnology and life sciences, including PhD-level scientists, doctors and other medical professionals, biotech and healthcare entrepreneurs, specialist investors, and life science consultants, all with at least six years of industry or research experience.
“Continuously new projects, very interesting to see what people are thinking about and what they are focusing on.”
Benefits for BEN Members
Professional Growth and Networking
BEN members gain early access to innovative R&D proposals, keeping up to date with the latest advances in their field and helping to shape the future of medicine. The BEN is also a great way to expand your professional network and strengthen your professional reputation, while making a real difference to society.
Life Science Investment Credits
In addition, experts receive investment credits for their reviews, which they can invest in early-stage startups at Capital Cell – the very companies they helped to select. The value of their invested credits grows with the share value of the companies and can be cashed in when an exit event takes place.
“The concept is a community of experts in different fields helping each other in a free form.”
In a 2022 survey of our active experts, motivations for participating included:
82%
Discovering new companies
79%
Helping entrepreneurs
82%
Learning
79%
Receiving investment credits
82%
Strengthening professional reputation
79%
Fun
